Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors:: Initial experience in 26 patients

被引:104
|
作者
Kettenbach, J
Köstler, W
Rücklinger, E
Gustorff, B
Hüpfl, M
Wolf, F
Peer, K
Weigner, M
Lammer, J
Müller, W
Goldberg, SN
机构
[1] Univ Vienna, Sch Med, Dept Diagnost Radiol, Div Angiog & Intervent Radiol, A-1090 Vienna, Austria
[2] Stat Anal Method Consulting, A-1200 Vienna, Austria
[3] Univ Vienna, Dept Anesthesiol & Intens Care B, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Radiotherapy, A-1090 Vienna, Austria
[5] Wilhelminenspital Stadt Wien, A-1160 Vienna, Austria
[6] Univ Dept Biomed Engn, Fachhsch Furtwangen, D-78054 Villingen Schwenningen, Germany
[7] Beth Israel Deaconess Med Ctr, Dept Radiol, Harvard Med Sch, Boston, MA 02215 USA
关键词
D O I
10.2214/ajr.180.6.1801537
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective. The purpose of our study was to evaluate the safety and efficacy of percutaneous saline-enhanced radiofrequency ablation for unresectable primary or metastatic hepatic tumors. Subjects and Methods. Twenty-six patients with 15 hepatocellular carcinomas and 33 hepatic metastases (maximum diameter less than or equal to8.6 cm) were treated; of these, seven tumors in five patients were treated twice. Thus, 44 radiofrequency treatments were performed. Saline-enhanced and impedance-controlled radiofrequency ablation (0.5-1.1 mL/min of saline, 15-mm conductive portion of the electrode tip, 25-60 W, 5-43 min) was performed using MR imaging guidance. Coagulation necrosis, volume indexes, morbidity, and complications were assessed. Results. The volume of coagulation necrosis 1-7 days after radiofrequency ablation was 1.6-126.6 cm(3) (median, 18.9 cm(3)), corresponding to coagulation diameters of 1.5-6.2 cm (median, 3.2 cm). The coagulation volume was significantly larger if there were more than four radiofrequency applications (p=0.006). Tumors of 3 cm or less in diameter were eight times as likely to be successfully completely ablated (p=0.01) and volume indexes of lesions treated with the patient under general anesthesia were significantly larger than those treated with the patient under conscious sedation (p<0.001). Major complications occurred in four patients (15%). Incomplete ablation in 19 (35%) of 54 radiofrequency lesions was due to cooling by a large vessel nearby (n=2) or to low power applied in painful (n=11) or critical (n=6) locations. Residual tumor was observed in 14 (58%) of 24 tumors evaluated 6-8 months after radiofrequency ablation. Conclusion. Percutaneous saline-enhanced and impedance-controlled radiofrequency ablation can be effective in the treatment of unresectable hepatic tumors and minimizes potential carbonization. A greater number of radiofrequency applications, general anesthesia, and increasing experience provide significantly better results.
引用
收藏
页码:1537 / 1545
页数:9
相关论文
共 50 条
  • [1] Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma
    Giorgio, A
    Tarantino, L
    de Stefano, G
    Scala, V
    Liorre, G
    Scarano, F
    Perrotta, A
    Farella, N
    Aloisio, V
    Mariniello, N
    Coppola, C
    Francica, G
    Ferraioli, G
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (02) : 479 - 484
  • [2] Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors: 3-year experience with 336 patients at a single center
    Giorgio, A
    Tarantino, L
    de Stefano, G
    Coppola, C
    Ferraioli, G
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 184 (01) : 207 - 211
  • [3] Hepatic lesion ablation with bipolar saline-enhanced radiofrequency in the audible spectrum
    Burdío, F
    Güemes, A
    Burdío, JM
    Castiella, T
    De Gregorio, MA
    Lozano, R
    Livraghi, T
    ACADEMIC RADIOLOGY, 1999, 6 (11) : 680 - 686
  • [5] Radiofrequency ablation for unresectable hepatic tumors
    Wong, SL
    Edwards, MJ
    Chao, C
    Simpson, D
    McMasters, KM
    AMERICAN JOURNAL OF SURGERY, 2001, 182 (06): : 552 - 557
  • [6] Multipolar radiofrequency ablation of hepatic tumors: Initial experience
    Frericks, BB
    Ritz, JP
    Roggan, A
    Wolf, KJ
    Albrecht, T
    RADIOLOGY, 2005, 237 (03) : 1056 - 1062
  • [7] Automated saline-enhanced radiofrequency thermal ablation:: Initial results in ex vivo bovine livers
    Schmidt, D
    Trübenbach, J
    Brieger, J
    Koenig, C
    Putzhammer, H
    Duda, SH
    Claussen, CD
    Pereira, PL
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (01) : 163 - 165
  • [8] Artificially induced pneumothorax for percutaneous transthoracic radiofrequency ablation of tumors in the hepatic dome:: Initial experience
    de Baère, T
    Dromain, C
    Lapeyre, M
    Briggs, P
    Duret, JS
    Hakime, A
    Boige, V
    Ducreux, M
    RADIOLOGY, 2005, 236 (02) : 666 - 670
  • [9] Percutaneous Radiofrequency Ablation of Peri-intestinal Hepatic Tumors: Initial Experience with Hydrodisplacement Technique
    Anaya, C.
    Gomez, A.
    Raman, S.
    Lu, D.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2007, 188 (05)
  • [10] Saline-enhanced radiofrequency thermal ablation of the lung: A feasibility study in rabbits
    Lee, JM
    Kim, SW
    Li, CA
    Youk, JH
    Kim, YK
    Jin, ZW
    Chung, MJ
    Lee, MS
    KOREAN JOURNAL OF RADIOLOGY, 2002, 3 (04) : 245 - 253